Valuation: Zoetis Inc.

Market Cap 31.95B 28B 25.94B 23.88B 45.03B 3,077B 45.57B 310B 121B 1,508B 120B 117B 5,206B P/E 2026 *
11.9x
P/E 2027 * 10.9x
Enterprise Value 38.67B 33.9B 31.41B 28.91B 54.51B 3,724B 55.17B 375B 147B 1,825B 145B 142B 6,302B EV / Sales 2026 *
3.96x
EV / Sales 2027 * 3.72x
Free-Float
83.58%
Yield 2026 *
2.83%
Yield 2027 * 3.03%
1 day-1.29%
1 week+1.46%
Current month+4.58%
1 month-0.98%
3 months-36.41%
6 months-39.92%
Current year-40.27%
1 week 74.23
Extreme 74.23
78.05
1 month 71.47
Extreme 71.47
79.9
Current year 71.47
Extreme 71.47
132.49
1 year 71.47
Extreme 71.47
160.48
3 years 71.47
Extreme 71.47
201.92
5 years 71.47
Extreme 71.47
249.27
10 years 46.86
Extreme 46.86
249.27
Manager TitleAgeSince
Chief Executive Officer 54 31/12/2019
Director of Finance/CFO 54 31/05/2021
Chief Tech/Sci/R&D Officer 49 31/12/2025
Director TitleAgeSince
Director/Board Member 68 30/06/2012
Director/Board Member 68 31/12/2012
Chairman 73 25/06/2013
Date Insider Type Main position Quantity % Market Cap.
10/07/26 Free

Executive/Senior Manager

238 0.0001%
10/07/26 Free

Chief Financial Officer

363 0.0001%
10/07/26 Free

Executive Vice President

215 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%+1.46%-49.01%-59.05% 31.95B
+1.41%-0.47%+73.23%+111.56% 12.56B
-1.12%+2.05%-20.70%-2.21% 3.67B
+5.07%+6.21%-2.43%+28.09% 3.11B
+0.61%-2.70%+27.89%+13.40% 1.85B
-1.60%+9.40%-5.36%+23.72% 1.87B
+1.94%+1.57%+15.17%+124.63% 1.34B
+0.25%+2.66%-24.67%-11.95% 1.08B
-4.04%+4.90%-18.63%-46.85% 1.01B
+0.98%-0.14%-8.65%-20.13% 943M
Average +0.25%+0.22%-1.32%+16.12% 5.94B
Weighted average by Cap. -0.22%+0.72%-12.15%-4.20%

Financials

2026 *2027 *
Net sales 9.75B 8.55B 7.92B 7.29B 13.75B 939B 13.92B 94.55B 37B 460B 36.62B 35.83B 1,590B 10.15B 8.9B 8.24B 7.59B 14.31B 978B 14.48B 98.39B 38.5B 479B 38.1B 37.28B 1,654B
Net income 2.7B 2.37B 2.19B 2.02B 3.81B 260B 3.85B 26.17B 10.24B 127B 10.14B 9.92B 440B 2.93B 2.57B 2.38B 2.19B 4.14B 283B 4.19B 28.44B 11.13B 139B 11.02B 10.78B 478B
Net Debt 6.73B 5.9B 5.46B 5.03B 9.48B 648B 9.6B 65.19B 25.51B 317B 25.25B 24.7B 1,096B 5.82B 5.11B 4.73B 4.35B 8.21B 561B 8.31B 56.46B 22.09B 275B 21.86B 21.39B 949B
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
14,500
Date Price Change Volume
21/07/26 US$75.48 -0.95% 3,073,853
20/07/26 US$76.20 -0.47% 5,635,719
17/07/26 US$76.56 -0.46% 7,544,442
16/07/26 US$76.91 +3.19% 7,403,623
15/07/26 US$74.53 +0.62% 5,359,544
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
76.20USD
Average target price
114.76USD
Spread / Average Target
+50.61%

Quarterly revenue - Rate of surprise